NFKB1 and atherosclerosis: In this context, it has proved that calpain inhibition attenuates atherosclerosis and inflammation through eNOS/NO/NF-kB pathway in an animal model [51], and markedly reduces vascular remodeling induced by Angiotensin II [52].